Detalhe da pesquisa
1.
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
Ann Neurol
; 85(3): 359-370, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694576
2.
Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.
Sleep Med X
; 7: 100109, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601325
3.
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
CNS Drugs
; 36(4): 377-387, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380374
4.
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Sleep
; 45(6)2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358324
5.
Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
Sleep
; 31(10): 1359-70, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18853933
6.
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
Hum Psychopharmacol
; 23(1): 13-20, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17907263